FTC warns additional companies about deceptive claims of COVID-19 treatment

We posted two weeks ago that the Federal Trade Commission had sent warning letters to more than 25 companies to stop making unsubstantiated claims that their products could prevent or treat COVID-19

Last Thursday, the FTC sent 21 additional letters warning marketers throughout the United States to stop making unsubstantiated claims that their products and therapies can treat or prevent COVID-19. The deceptive claims concerned treatment by vitamins and other supplements, acupuncture, intravenous therapies, ozone therapies, and stem-cell treatments. The letters are available here.

Then on Friday, the FTC announced it had sent 10 letters warning multi-level marketing companies to remove and address claims that they or their participants were making about their products’ ability to treat or prevent coronavirus or about the earnings people who have recently lost income can make, or both. Those letters are available here.

The letters were sent between March 6 and April 24.

According to the Food and Drug Administration, there currently are no products proven to treat or prevent the virus.

Leave a Reply

Your email address will not be published. Required fields are marked *